Top compounds associated with response to MYBL2


Feature Type Standardized
Nominal ANOVA
mRNA dacarbazine CTRPv2 pan-cancer AAC 0.067 0.05
mRNA IC-87114 CTRPv2 pan-cancer AAC 0.079 0.05
mRNA Bicalutamide GDSC1000 pan-cancer AAC -0.071 0.05
mRNA AZD8055 CTRPv2 pan-cancer AAC 0.075 0.05
mRNA Curcumin CTRPv2 pan-cancer AAC 0.072 0.05
mRNA alvocidib CTRPv2 pan-cancer AAC 0.1 0.05
mRNA tandutinib CTRPv2 pan-cancer AAC -0.077 0.05
mRNA JQ12 GDSC1000 pan-cancer AAC -0.073 0.05
mRNA ML006 CTRPv2 pan-cancer AAC 0.077 0.05
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.07 0.05
Download CSV